Edition:
United States

Zhejiang Medicine Co Ltd (600216.SS)

600216.SS on Shanghai Stock Exchange

9.14CNY
16 Nov 2018
Change (% chg)

¥0.03 (+0.33%)
Prev Close
¥9.11
Open
¥9.11
Day's High
¥9.20
Day's Low
¥9.03
Volume
21,062,021
Avg. Vol
18,398,896
52-wk High
¥18.05
52-wk Low
¥7.81

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -- December 16 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 3 3 3
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.33 1.25 1.25 1.25

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-18 2 6,663.66 6,690.43 6,636.89 5,725.35
Year Ending Dec-19 2 7,475.65 7,677.27 7,274.04 6,016.80
Earnings (per share)
Year Ending Dec-18 2 0.68 0.73 0.63 0.40
Year Ending Dec-19 2 0.85 0.91 0.78 0.48

Historical Surprises

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Estimates vs Actual Estimate Actual Difference Surprise %
Earnings (per share)
Quarter Ending Dec-14 0.04 -0.14 0.18 442.50
Quarter Ending Sep-14 0.08 0.09 0.01 13.75
Quarter Ending Jun-14 0.05 0.13 0.08 160.00
Quarter Ending Dec-13 0.08 0.03 0.05 61.25
Quarter Ending Sep-13 0.34 0.13 0.21 62.82

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-18 6,663.66 6,663.66 6,909.11 6,909.11 5,725.35
Year Ending Dec-19 7,475.65 7,475.65 7,612.44 7,612.44 6,016.80
Earnings (per share)
Year Ending Dec-18 0.68 0.68 0.79 0.92 0.40
Year Ending Dec-19 0.85 0.85 0.84 0.90 0.48

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0